ICAM1 and Recurrent upper respiratory tract infections: Alternatively, upregulation of ICAM1 the primary ligand for rhinovirus [28] could increase the susceptibility to, or severity of upper respiratory tract infection, resulting in upper airway oedema and/or adenoid hypertrophy.